Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge
NCT ID: NCT00642681
Last Updated: 2014-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2007-12-31
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1: TI Inhalation Powder
Technosphere® Insulin (TI) Inhalation Powder
Technosphere Insulin
Technosphere® Insulin (TI) Inhalation Powder, prandial
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Technosphere Insulin
Technosphere® Insulin (TI) Inhalation Powder, prandial
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 3 URI symptoms
Exclusion Criteria
* MedHist, PE or lab findings of acute bacterial infection including but not limited to sputum prod., nasal/eye discharge, chest exam abnormalities, CXR findings of pneumonia.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mannkind Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona Research Associates
Tuscon, Arizona, United States
Valley Research (Norwood)
Fresno, California, United States
Diabetes/Lipid Management and Research Center
Huntington Beach, California, United States
Private Practice
Decatur, Georgia, United States
Endocrine Research Solutions, Inc.
Roswell, Georgia, United States
Cedar-Crosse Research Center
Chicago, Illinois, United States
MODEL Clinical Research
Baltimore, Maryland, United States
Healthcare Research
Florissant, Missouri, United States
Billings Clinic Research Division
Billings, Montana, United States
New Mexico Clinical Research & Osteoporosis Center
Albuquerque, New Mexico, United States
M.E.R.I.
New York, New York, United States
Rapid Medical Research Inc
Cleveland, Ohio, United States
Your Diabetes Endocrine Nutrition Group
Mentor, Ohio, United States
Diabetes & Glandular Disease Research Assoc PA
San Antonio, Texas, United States
Magna Center for Family Medicine
Magna, Utah, United States
Parkwood Hospital
London, Ontario, Canada
Kemerovo State Medical Academy of Ministry of Health
Kemerovo, RUS, Russia
NHI Kemerovo Regional Clinical Hospital
Kemerovo, RUS, Russia
Russian State Medical University City Hospital # 4
Moscow, RUS, Russia
RAAMS Endocrinology and Diabetology Department
Moscow, RUS, Russia
Clinical Pharm Dept of Yaroslavl Clin Hospital
Yaroslavl, RUS, Russia
NHI Yaroslavl Regional Clinical Hospital
Yaroslavl, RUS, Russia
Yaroslavl Regional Clinical Hospital
Yaroslavl, RUS, Russia
FSI Principal Military Clinical Hospital n.a. academician N.N. Burdenko of the Ministry of Defense
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MKC-TI-112
Identifier Type: -
Identifier Source: org_study_id